By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 114.51 |
Change Today | $ 0.00 |
% Change | 0.00 % |
52 Week High | $117.41 |
52 Week Low | $72.73 |
Volume | 2,441 |
Shares Issued | 1,246.00m |
Market Cap | $142,680m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 10 |
Neutral | 7 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
You are here: research